Evidence map›Paper›PMID 26306329›Full record

ArticleJournal of reward deficiency syndrome

The Molecular Neurobiology of Twelve Steps Program & Fellowship: Connecting the Dots for Recovery.

Kenneth Blum, Benjamin Thompson, Zsolt Demotrovics, John Femino, John Giordano, Marlene Oscar-Berman, Scott Teitelbaum, David E Smith, A Kennison Roy, Gozde Agan and 3 more

Open access · diamondAbstract read
In one paragraph

Article in Journal of reward deficiency syndrome. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 1 pooled it
1.4field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 1 synthesis or guideline pooled it, 72 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. A Comprehensive 4-layeredCurrent pharmaceutical biotechnology · 2025
    Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Reward Deficiency Syndrome (RDS): A Cytoarchitectural Common Neurobiological Trait of All Addictions.International journal of environmental research and public health · 2021
    Article
  13. Article
  14. Article
  15. Death by Opioids: Are there non-addictive scientific solutions?Journal of systems and integrative neuroscience · 2019
    Article
  16. Promoting Precision Addiction Management (PAM) to Combat the Global Opioid Crisis.Biomedical journal of scientific & technical research · 2018
    Article
  17. The Benefits of Genetic Addiction Risk Score (GARSInternational journal of genomics and data mining · 2018
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 2 countries.

Kenneth BlumDepartment of Psychiatry, School of Medicine and McKnight Brain Institute, University of Florida, Gainesville, FL, USA ; Department of Addiction Research and Therapy, Malibu Beach Recovery Center, Malibu Beach, CA, USA ; Dominion Diagnostics, Inc., North Kingstown, RI, USA ; IGENE, LLC., Austin, TX, USA ; RDSolutions, Del Mar, CA, USA ; National Institute for Holistic Medicine, North Miami Beach, FL, USA.
Benjamin ThompsonBehavioral Neuroscience Program, Boston University School of Medicine, and Boston VA Healthcare System, Boston, MA, USA.
Zsolt DemotrovicsEötvös Loránd University, Institute of Psychology, Budapest, Hungary.
John FeminoDominion Diagnostics, Inc., North Kingstown, RI, USA ; Meadows Edge Recovery Center, North Kingstown, RI, USA.
John GiordanoNational Institute for Holistic Medicine, North Miami Beach, FL, USA.
Marlene Oscar-BermanDepartments of Psychiatry, Neurology, and Anatomy & Neurobiology, Boston University School of Medicine, and Boston VA Healthcare System, Boston, MA, USA.
Scott TeitelbaumDepartment of Psychiatry, School of Medicine and McKnight Brain Institute, University of Florida, Gainesville, FL, USA.
David E SmithDominion Diagnostics, Inc., North Kingstown, RI, USA ; Institute of Health & Aging, University of California at San Francisco, San Francisco, CA, USA.
A Kennison RoyBiobehavioral Medical Corporation, Metairie, LA, USA.
Gozde AganDominion Diagnostics, Inc., North Kingstown, RI, USA.
James FratantonioDominion Diagnostics, Inc., North Kingstown, RI, USA.
Rajendra D BadgaiyanDepartment of Psychiatry, University of Minnesota College of Medicine, Minneapolis, MN, USA.
Mark S GoldDirector of Research, Drug Enforcement Administration (DEA) Educational Foundation, Washington, D.C, USA ; Departments of Psychiatry & Behavioral Sciences at the Keck, University of Southern California, School of Medicine, CA, USA.
Dominion Diagnostics (United States) · USEötvös Loránd University · HUUniversity of Florida · USUniversity of Minnesota · US

Funding

AFFECTIVE AND CONATIVE CHANGES IN ALCOHOLISMR01AA007112 · NIAAA · BOSTON UNIVERSITY MEDICAL CAMPUS · PI BERMAN, MARLENE OSCAR · 1987 to 2019
$8.3M
Dopamine Neurotransmission in Tourette SyndromeR01NS073884 · NINDS · UNIVERSITY OF MINNESOTA · PI BADGAIYAN, RAJENDRA D · 2012 to 2016
$2.2M
AFFECTIVE AND CONATIVE CHANGES IN ALCOHOLISMK05AA000219 · NIAAA · BOSTON UNIVERSITY MEDICAL CAMPUS · PI BERMAN, MARLENE OSCAR · 1997 to 2011
$1.8M
Detection of Dopamine Release During a Cognitive TaskR21MH073624 · NIMH · MASSACHUSETTS GENERAL HOSPITAL · PI BADGAIYAN, RAJENDRA D · 2005 to 2006
$368k
Dopamine Neurotransmission in AddictionI01CX000479 · VA · VA WESTERN NEW YORK HEALTHCARE SYSTEM · PI BADGAIYAN, RAJENDRA D · 2013 to 2014
–
CSRD VA I01 CX000479NIAAA NIH HHS K05 AA000219NIAAA NIH HHS R01 AA007112NIMH NIH HHS R21 MH073624NINDS NIH HHS R01 NS073884
6 · The paper itself

Abstract

There are some who suggest that alcoholism and drug abuse are not diseases at all and that they are not consequences of a brain disorder as espoused recently by the American Society of Addiction Medicine (ASAM). Some would argue that addicts can quit on their own and moderate their alcohol and drug intake. When they present to a treatment program or enter the 12 Step Program & Fellowship, many addicts finally achieve complete abstinence. However, when controlled drinking fails, there may be successful alternatives that fit particular groups of individuals. In this expert opinion, we attempt to identify personal differences in recovery, by clarifying the molecular neurobiological basis of each step of the 12 Step Program. We explore the impact that the molecular neurobiological basis of the 12 steps can have on Reward Deficiency Syndrome (RDS) despite addiction risk gene polymorphisms. This exploration has already been accomplished in part by Blum and others in a 2013 Springer Neuroscience Brief. The purpose of this expert opinion is to briefly, outline the molecular neurobiological and genetic links, especially as they relate to the role of epigenetic changes that are possible in individuals who regularly attend AA meetings. It begs the question as to whether "12 steps programs and fellowship" does induce neuroplasticity and continued dopamine D2 receptor proliferation despite carrying hypodopaminergic type polymorphisms such as DRD2 A1 allele. "Like-minded" doctors of ASAM are cognizant that patients in treatment without the "

Indexed as

12 stepsDopamine agonistic modalities (DAM)FellowshipGenetic testingGodNeuroepigeneticsReward deficiency syndrome (RDS)Spirituality

Identifiers

PMID26306329
PMCPMC4545669
OpenAlexW2096833663

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.